DEU0001728MA - - Google Patents
Info
- Publication number
- DEU0001728MA DEU0001728MA DEU0001728MA DE U0001728M A DEU0001728M A DE U0001728MA DE U0001728M A DEU0001728M A DE U0001728MA
- Authority
- DE
- Germany
- Prior art keywords
- dione
- pregnen
- same
- steroids
- acetone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 150000003431 steroids Chemical class 0.000 claims description 10
- 241000233866 Fungi Species 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 241001450870 Thamnostylum piriforme Species 0.000 claims description 5
- 230000001590 oxidative effect Effects 0.000 claims description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 241001450823 Helicostylum Species 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 3
- 241000235388 Mucorales Species 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- -1 acyl ester Chemical class 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- HBGALFVDRUBTCE-UHFFFAOYSA-N 1,2-dichloroethane;propan-2-one Chemical compound CC(C)=O.ClCCCl HBGALFVDRUBTCE-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000010822 slaughterhouse waste Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE948686C (de) | Verhfahren zur Herstellung von 4-Pregnen-14ª‡, 17ª‡,21-triol-3,20-dion | |
| DEU0001728MA (enrdf_load_stackoverflow) | ||
| DE951444C (de) | Verfahren zur Herstellung von 4-Pregnen-8, 17ª‡, 21-triol-3, 20-dion | |
| DEU0001745MA (enrdf_load_stackoverflow) | ||
| DE937054C (de) | Verfahren zur Herstellung von 11ª‡-Oxy-6-dehydroprogesteron | |
| DE937055C (de) | Verfahren zur Herstellung von 6ª‰, 17ª‡-Dioxyprogesteron | |
| DE937056C (de) | Verfahren zur Herstellung von 5-Pregnen-3ª‰, 7ª‡, 11ª‡-triol-20-on | |
| DE937052C (de) | Verfahren zur Herstellung von 4-Androsten-11ª‡-ol-3, 17-dion | |
| DE937053C (de) | Verfahren zur Herstellung von 11ª‡-Oxytestosteron bzw. 11ª‡-Oxy-10-normethyltestosteron | |
| DE937051C (de) | Verfahren zur Herstellung von 3-Ketobisnor-4-cholen-11ª‡, 22-diol und bzw. oder 3-Ketobisnor-4-cholentriol | |
| DE1229522B (de) | Verfahren zur Herstellung von Cycloalkanolen und/oder Cycloalkanonen sowie von Estern der Cycloalkanole | |
| DE1620628A1 (de) | Verfahren zur Einfuehrung von Sauerstoff in den hetrozyklischen Ring von N-Acylderivaten in Polymethyleniminen und Azabicycloalkanen | |
| DE1134670B (de) | Verfahren zur katalytischen Acylierung von Oxyverbindungen | |
| DE1445529A1 (de) | Verfahren zur Herstellung von trans-2-Phenyl-3-methylmorpholin | |
| DEU0001734MA (enrdf_load_stackoverflow) | ||
| DE1113690B (de) | Verfahren zur Herstellung von in 11-Stellung durch sauerstoffhaltige Gruppen substituierten 16-Methyl-1, 4-pregnadien-17ª‡-ol-3, 20-dion-Verbindungen | |
| DE1107225B (de) | Verfahren zur Herstellung von 1, 4, 17(20)-Pregnatrienen | |
| DE1768203C3 (de) | Verfahren zur Herstellung von 3 ß, 11 ß-Hydroxy-5 a, 6 a- epoxysteroiden auf mikrobiologischem Wege | |
| DD248596A1 (de) | Verfahren zur isolierung von androsta-3,17-dionen aus rohextrakten | |
| AT239453B (de) | Verfahren zur Herstellung 18-oxygenierter Steroide | |
| DE928833C (de) | Verfahren zur Herstellung von Normal- bzw. Allopregnan-3, 11, 20-trion | |
| DE1128854B (de) | Verfahren zur Herstellung von 11-hydroxylierten Steroiden der Pregnanreihe | |
| DE1009627B (de) | Verfahren zur Herstellung von 4-Pregnen-11ª‰, 17ª‡- 21-triol-3,20-dion (Hydrocortison) und 4-Pregnen-11ª‡, 17ª‡, 21-triol-3,20-dion (11-epi-Hydrocortison) | |
| DEU0002026MA (enrdf_load_stackoverflow) | ||
| DD266592A1 (de) | Verfahren zur herstellung von 11beta, 15beta-dihydroxy-(20s)-20-hydroxymethyl-1,4-pregnadien-3-on |